Reametrix India Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
- Paid Up Capital ₹ 1.73 Cr
- Company Age 23 Year, 21 Days
- Last Filing with ROC 31 Mar 2019
- Revenue Growth %
- Profit Growth 96.04%
- Ebitda 86.29%
- Net Worth -1.50%
- Total Assets -0.61%
About Reametrix India
Reametrix India Private Limited (RIPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 January 2002 and has a history of 23 years. Its registered office is in Bangaluru, Karnataka, India.
The Corporate was formerly known as Prescientis India Private Limited. The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.73 Cr, as per Ministry of Corporate Affairs (MCA) records.
Anurag Bagaria and Bala Manian serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U73100KA2002PTC030005
-
Company No.
030005
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Jan 2002
-
Date of AGM
30 Sep 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Reametrix India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anurag Bagaria
|
Director | 22-Apr-2010 | Current |
Bala Manian
|
Director | 04-Mar-2004 | Current |
Financial Performance of Reametrix India.
Reametrix India Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 96.04% increase in profit. The company's net worth dipped by a decrease of 1.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Reametrix India?
In 2018, Reametrix India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Stempeutics Research Private LimitedAnurag Bagaria is a mutual person
-
Kemwell Biopharma Private LimitedAnurag Bagaria is a mutual person
-
Hemogenomics Private LimitedAnurag Bagaria is a mutual person
-
Max Medisupport LlpAnurag Bagaria is a mutual person
-
North East Gases Pvt Ltd
Anurag Bagaria is a mutual person
-
Bioworth India Pvt Ltd
Anurag Bagaria is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Reametrix India?
Reametrix India has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Reametrix India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reametrix India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
